COVID-19 preclinical drug development database
Development of PET radioligands for imaging ACE2 receptors
University of Cambridge
Added 04/11/2021 | Updated 04/11/2021
Project Details
Type of project
- Supporting technologies, models and assays
Therapeutic target
Type of supporting technology
- In vivo imaging technology
Phase of project
Modality (if can be disclosed)*
Molecular/cellular target (if known or can be disclosed)*
Partner institutions/organisations
- University of Oxford
Key contact
Name: Franklin Aigbirhio
Email Address: [email protected]
Phone Number: 01223 331823
Key Collaborators:
Franklin Aigbirhio , Dept of Clinical Neurosciences, Unversity of Cambridge
Andreas Bender , Dept of Chemistry, University of Cambridge
Veronique Gouverneur, Dept of Chemistry, Oxford
Anticipated timeframe of future outputs
12+ months